DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Isoniazid (Isoniazid) - Current Clinical Trials


Isoniazid Related Clinical Trials

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection [Completed]

Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana [Completed]

Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2) [Terminated]

TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment [Completed]

A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts [Completed]

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons [Completed]

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention [Recruiting]

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis [Completed]

"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients". [Terminated]

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children [Active, not recruiting]

Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan [Recruiting]

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [Completed]

High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis [Completed]

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV [Terminated]

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation [Recruiting]

Isoniazid (INH) Treatment Based on ELISPOT Assay [Completed]

TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance [Completed]

Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria [Enrolling by invitation]

NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis [Recruiting]

TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [Completed]

Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection [Terminated]

Treatment of Latent Tuberculosis Infection With Isoniazid [Completed]

Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) [Active, not recruiting]

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [Completed]

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) [Recruiting]

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis [Completed]

ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study) [Active, not recruiting]

Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) [Completed]

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women [Recruiting]

Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) [Active, not recruiting]

Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya [Completed]

NAT2 in Re-challenge of INH in Patients With Hepatitis [Recruiting]

Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection [Active, not recruiting]

Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) [Completed]

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT [Completed]

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) [Completed]

Early Bactericidal Activity (EBA) Study of Tuberculosis Regimens With and Without INH and Moxifloxacin [Recruiting]

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB [Not yet recruiting]

Treatment of Latent TB Infection for Jailed Persons [Completed]

Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness [Active, not recruiting]

TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection [Completed]

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination [Completed]

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis [Completed]

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis [Active, not recruiting]

Research on New Regimens for Retreatment Pulmonary Tuberculosis [Recruiting]

Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI) [Active, not recruiting]

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults [Completed]

Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users [Active, not recruiting]

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design [Active, not recruiting]

Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis [Completed]

Early Bactericidal Activity Study of Faropenem(With Amoxicillin/Clavulanic Acid)in Patients With Pulmonary Tuberculosis [Recruiting]

Preventive Therapy for Tuberculosis in HIV Infected Persons [Active, not recruiting]

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis [Not yet recruiting]

A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers [Completed]

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes [Recruiting]

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [Completed]

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [Completed]

QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. [Active, not recruiting]

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [Completed]

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [Completed]

Assessing PA-824 for Tuberculosis (the APT Trial) [Recruiting]

Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB [Active, not recruiting]

PK Study of Anti-TB Drugs [Not yet recruiting]

Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis [Recruiting]

Tuberculosis Treatment Shortening Trial [Completed]

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers [Completed]

Latency in Pulmonary Tuberculosis [Recruiting]

Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment [Recruiting]

Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity [Completed]

Shortening Treatment by Advancing Novel Drugs [Recruiting]

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 [Recruiting]

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment [Active, not recruiting]

The Treatment of Tuberculosis in HIV-Infected Patients [Completed]

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [Completed]

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine [Completed]

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis [Active, not recruiting]

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [Completed]

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) [Completed]

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection [Completed]

Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison [Completed]

Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity [Completed]

Brief Bactericidal Activity of Anti-Tuberculosis Drugs [Not yet recruiting]

Do Clinical Decision-support Reminders for Medical Providers Improve the Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya? [Not yet recruiting]

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy [Active, not recruiting]

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy [Completed]

Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis [Completed]

Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [Recruiting]

A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. [Recruiting]

Tuberculosis Prevention for HIV Infected Adults [Completed]

Efficacy of Antituberculous Therapy in Management of Sarcoidosis [Completed]

Patients Response to Early Switch To Oral:Osteomyelitis Study [Not yet recruiting]

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment [Terminated]

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Completed]

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens [Not yet recruiting]

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis [Completed]

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana [Recruiting]

Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease [Recruiting]

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment [Completed]

Determining Risk in Latent Tuberculosis [Terminated]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017